These findings support the concept that the synergistic combination therapy of GAN and MTX-induced apoptosis might be associated with not only the mitochondrial apoptotic pathway, which is particularly relevant to cancer, but also with the typical apoptotic signaling pathway as well. Here, GAN is linked to cancer.